Strategies targeting the IL-4/IL-13 axes in disease.

[1]  T. Forsthuber,et al.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. , 2015, Cytokine.

[2]  D. Postma,et al.  Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. , 2015, American journal of respiratory and critical care medicine.

[3]  Jonathan R. Brestoff,et al.  Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity , 2014, Nature.

[4]  Meenu Sharma,et al.  Autoimmunity: Basophils in autoimmune and inflammatory diseases , 2015, Nature Reviews Rheumatology.

[5]  K. Schäkel,et al.  IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells , 2015, Proceedings of the National Academy of Sciences.

[6]  Y. Shoenfeld,et al.  The mechanisms behind helminth's immunomodulation in autoimmunity. , 2015, Autoimmunity reviews.

[7]  Alkis Togias,et al.  Clinical practice. Allergic rhinitis. , 2015, The New England journal of medicine.

[8]  R. Locksley,et al.  Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis , 2015, Cell.

[9]  W. Reinisch,et al.  Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study , 2015, Gut.

[10]  I. Pavord,et al.  Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease , 2015, The Journal of allergy and clinical immunology.

[11]  S. Abrignani,et al.  Plasticity of Human CD4 T Cell Subsets , 2014, Front. Immunol..

[12]  N. Papadopoulos,et al.  IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. , 2014, American journal of respiratory and critical care medicine.

[13]  P. Schwille,et al.  Dynamics and interaction of interleukin-4 receptor subunits in living cells. , 2014, Biophysical journal.

[14]  G. Yancopoulos,et al.  Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. , 2014, The Journal of allergy and clinical immunology.

[15]  Ruth R. Montgomery,et al.  IL-6 receptor α defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthma. , 2014, American journal of respiratory and critical care medicine.

[16]  E. Bleecker,et al.  Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. , 2014, The Lancet. Respiratory medicine.

[17]  Christophe Pellefigues,et al.  Immunoglobulin E plays an immunoregulatory role in lupus , 2014, The Journal of experimental medicine.

[18]  L. Peyrin-Biroulet,et al.  Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study , 2014, Gut.

[19]  Lu Gao,et al.  Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. , 2014, Cancer letters.

[20]  M. Yazdanbakhsh,et al.  Priming Dendritic Cells for Th2 Polarization: Lessons Learned from Helminths and Implications for Metabolic Disorders , 2014, Front. Immunol..

[21]  W. Leonard,et al.  Complex interactions of transcription factors in mediating cytokine biology in T cells , 2014, Immunological reviews.

[22]  H. Kita,et al.  Enhanced innate type 2 immune response in peripheral blood from patients with asthma. , 2014, The Journal of allergy and clinical immunology.

[23]  G. Ogg,et al.  MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion , 2014, Immunity.

[24]  F. Bushman,et al.  Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation , 2014, Science.

[25]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[26]  T. Bieber,et al.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. , 2014, The New England journal of medicine.

[27]  H. Collard,et al.  Endogenously Expressed IL-13Rα2 Attenuates IL-13–Mediated Responses but Does Not Activate Signaling in Human Lung Fibroblasts , 2014, The Journal of Immunology.

[28]  M. Suárez-Fariñas,et al.  Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. , 2014, The Journal of allergy and clinical immunology.

[29]  Y. Koh,et al.  Increased Th2-like Invariant Natural Killer T cells in Peripheral Blood From Patients With Asthma , 2014, Allergy, asthma & immunology research.

[30]  F. Martinez,et al.  Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. , 2014, American journal of respiratory cell and molecular biology.

[31]  Charles C. Kim,et al.  Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion , 2014, Nature Immunology.

[32]  S. Wenzel,et al.  Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial. , 2014, The Journal of allergy and clinical immunology.

[33]  R. Sainson,et al.  Regulation of the anti-tumour immune response by cancer-associated fibroblasts. , 2014, Seminars in cancer biology.

[34]  David Artis,et al.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis , 2014, Nature Reviews Immunology.

[35]  R. Puri,et al.  IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis , 2014, Gut.

[36]  R. Maciuca,et al.  Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials , 2014 .

[37]  G. Corazza,et al.  Absence of a role for interleukin‐13 in inflammatory bowel disease , 2014, European journal of immunology.

[38]  Kori L Wallace,et al.  Immunopathology of inflammatory bowel disease. , 2014, World journal of gastroenterology.

[39]  G. Rogler,et al.  Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn’s disease , 2014, European journal of gastroenterology & hepatology.

[40]  N. Jarjour,et al.  The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[41]  M. Takeya,et al.  Clinical significance of macrophage heterogeneity in human malignant tumors , 2013, Cancer science.

[42]  N. Eissa,et al.  Regulation of IL-4 receptor signaling by STUB1 in lung inflammation. , 2013, American journal of respiratory and critical care medicine.

[43]  Thomas Blicher,et al.  A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations , 2013, Nature Genetics.

[44]  D. Voehringer,et al.  IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis , 2013, Proceedings of the National Academy of Sciences.

[45]  H. Saito,et al.  Cell type‐dependent effects of corticosteroid on periostin production by primary human tissue cells , 2013, Allergy.

[46]  F. Chew,et al.  Association of interleukin-13 SNP rs20541 (Arg>Gln) to allergic rhinitis in an Asian population of ethnic Chinese in Singapore. , 2013, Gene.

[47]  E. Geissler,et al.  IL-13 signaling via IL-13Ralpha2 triggers TGF-beta1-dependent allograft fibrosis , 2013 .

[48]  G. Schiechl,et al.  IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis , 2013, Transplantation research.

[49]  P. Krammer,et al.  Targeting the IL‐4/IL‐13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs , 2013, International journal of cancer.

[50]  S. Mosesova,et al.  Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. , 2013, The Journal of allergy and clinical immunology.

[51]  Y. Modis,et al.  Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2 , 2013, Cell reports.

[52]  M. Citardi,et al.  IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. , 2013, American journal of respiratory and critical care medicine.

[53]  D. Scott,et al.  STAT6 Controls the Number of Regulatory T Cells In Vivo, Thereby Regulating Allergic Lung Inflammation , 2013, The Journal of Immunology.

[54]  M. Suárez-Fariñas,et al.  Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.

[55]  L. Liang,et al.  A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis , 2013, Human molecular genetics.

[56]  Jack Bevers,et al.  Development of a Human IgG4 Bispecific Antibody for Dual Targeting of Interleukin-4 (IL-4) and Interleukin-13 (IL-13) Cytokines* , 2013, The Journal of Biological Chemistry.

[57]  M. Croft,et al.  Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. , 2013, The Journal of allergy and clinical immunology.

[58]  C. Garlanda,et al.  Tumor associated macrophages and neutrophils in tumor progression , 2013, Journal of cellular physiology.

[59]  Y. Vugmeyster,et al.  An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in mice. , 2013, American journal of respiratory cell and molecular biology.

[60]  S. Wenzel,et al.  Dupilumab in persistent asthma with elevated eosinophil levels. , 2013, The New England journal of medicine.

[61]  M. Vecchi,et al.  The Role of IL-33 in Gut Mucosal Inflammation , 2013, Mediators of inflammation.

[62]  M. Kraft,et al.  Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-&bgr;1 in airway fibroblasts in asthma , 2013, European Respiratory Journal.

[63]  Q. Xiu,et al.  The interleukin-4 -589C/T polymorphism and the risk of asthma: a meta-analysis including 7,345 cases and 7,819 controls. , 2013, Gene.

[64]  E. R. Sutherland,et al.  IL‐13‐producing BLT1‐positive CD8 cells are increased in asthma and are associated with airway obstruction , 2013, Allergy.

[65]  Giuseppina Stifano,et al.  Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β. , 2013, Arthritis and rheumatism.

[66]  M. Loza,et al.  Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study. , 2013, British journal of clinical pharmacology.

[67]  Sang-Uk Seo,et al.  Role of the gut microbiota in immunity and inflammatory disease , 2013, Nature Reviews Immunology.

[68]  A. Vetuschi,et al.  Can we prevent, reduce or reverse intestinal fibrosis in IBD? , 2013, European review for medical and pharmacological sciences.

[69]  M. Ultsch,et al.  Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab. , 2013, Journal of molecular biology.

[70]  R. Deo,et al.  Type 2 Innate Signals Stimulate Fibro/Adipogenic Progenitors to Facilitate Muscle Regeneration , 2013, Cell.

[71]  R. Clark,et al.  CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. , 2013, The Journal of investigative dermatology.

[72]  R. Locksley,et al.  Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.

[73]  D. Kwiatkowski,et al.  The 5q31 region in two African populations as a facet of natural selection by infectious diseases , 2013, Russian Journal of Genetics.

[74]  A. Lawson,et al.  The discovery, engineering and characterisation of a highly potent anti-human IL-13 fab fragment designed for administration by inhalation. , 2013, Journal of molecular biology.

[75]  H. Ren,et al.  First-in-Human Study of REGN668/SAR231893 (IL-4Rα mAb): Safety, Tolerability and Biomarker Results of a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers , 2013 .

[76]  V. Shi,et al.  IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis. , 2013, Cytokine.

[77]  S. Friedman,et al.  Therapy for Fibrotic Diseases: Nearing the Starting Line , 2013, Science Translational Medicine.

[78]  Kristopher J. Stanya,et al.  Direct control of hepatic glucose production by interleukin-13 in mice. , 2013, The Journal of clinical investigation.

[79]  P. Elias,et al.  The Th2 cytokine, interleukin‐4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis , 2013, Experimental dermatology.

[80]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[81]  K. T. Nguyen,et al.  Emerging Role of Human Basophil Biology in Health and Disease , 2013, Current Allergy and Asthma Reports.

[82]  E. D. De Boever,et al.  A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics. , 2013, British journal of clinical pharmacology.

[83]  T. Medsger,et al.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. , 2013, Arthritis and rheumatism.

[84]  M. Wills-Karp,et al.  Interactive effect of STAT6 and IL13 gene polymorphisms on eczema status: results from a longitudinal and a cross-sectional study , 2013, BMC Medical Genetics.

[85]  D. Nomura,et al.  Cutting Edge: IL-13Rα1 Expression in Dopaminergic Neurons Contributes to Their Oxidative Stress–Mediated Loss following Chronic Peripheral Treatment with Lipopolysaccharide , 2012, The Journal of Immunology.

[86]  M. Holtzman,et al.  IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. , 2012, The Journal of clinical investigation.

[87]  Chien-Ping Chiang,et al.  Eczema herpeticum: a medical emergency. , 2012, Canadian family physician Medecin de famille canadien.

[88]  W. Paul,et al.  Cytokines of the γc family control CD4+ T cell differentiation and function , 2012, Nature Immunology.

[89]  A. Qureshi,et al.  Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis , 2012, American Journal of Clinical Dermatology.

[90]  J. Foidart,et al.  Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma. , 2012, American journal of respiratory cell and molecular biology.

[91]  Deborah A Meyers,et al.  IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist. , 2012, The Journal of allergy and clinical immunology.

[92]  R. Puri,et al.  IL‐13 regulates cancer invasion and metastasis through IL‐13Rα2 via ERK/AP‐1 pathway in mouse model of human ovarian cancer , 2012, International journal of cancer.

[93]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[94]  C. Brightling,et al.  A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma , 2012, European Respiratory Journal.

[95]  M. Kabesch,et al.  Current concepts of IgE regulation and impact of genetic determinants , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[96]  J. Casal,et al.  High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. , 2012, Cancer research.

[97]  R. Müllenbach,et al.  IL-13 Signaling in Liver Fibrogenesis , 2012, Front. Immun..

[98]  T. Beaty,et al.  Functional Polymorphisms in IL13 Are Protective against High Schistosoma mansoni Infection Intensity in a Brazilian Population , 2012, PloS one.

[99]  Frank Koentgen,et al.  Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma , 2012, British journal of pharmacology.

[100]  R. Puri,et al.  IL-13 receptor-directed cancer vaccines and immunotherapy. , 2012, Immunotherapy.

[101]  J. Schulzke,et al.  Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics , 2012, The Journal of physiology.

[102]  S. Serrano,et al.  B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen , 2011, Nature Immunology.

[103]  G. Rogler,et al.  Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae , 2012, Gut.

[104]  R. Naidu,et al.  Polymorphic variants of interleukin-13 R130Q, interleukin-4 T589C, interleukin-4RA I50V, and interleukin-4RA Q576R in allergic rhinitis: A pilot study , 2012, Allergy & rhinology.

[105]  Jane Worthington,et al.  Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression , 2010, The Journal of Rheumatology.

[106]  J. Berzofsky,et al.  A Novel Combination Immunotherapy for Cancer by IL-13Rα2–Targeted DNA Vaccine and Immunotoxin in Murine Tumor Models , 2011, The Journal of Immunology.

[107]  The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge. , 2011, The Journal of allergy and clinical immunology.

[108]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[109]  J. Ring,et al.  Mutual antagonism of T cells causing psoriasis and atopic eczema. , 2011, The New England journal of medicine.

[110]  M. Boguniewicz,et al.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation , 2011, Immunological reviews.

[111]  K. Marquette,et al.  IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13Rα2 , 2011, The Journal of Immunology.

[112]  M. Kraft,et al.  Airway fibroblasts in asthma manifest an invasive phenotype. , 2011, American journal of respiratory and critical care medicine.

[113]  T. Medsger,et al.  GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. , 2011, Arthritis and rheumatism.

[114]  P. Kuna,et al.  Combined occurrence of filaggrin mutations and IL‐10 or IL‐13 polymorphisms predisposes to atopic dermatitis , 2011, Experimental dermatology.

[115]  E. Hoffman,et al.  Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous. , 2011, American journal of respiratory cell and molecular biology.

[116]  K. Rabe,et al.  IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides , 2011, Respiratory research.

[117]  S. Serrano,et al.  Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis , 2011, PloS one.

[118]  L. Boulet,et al.  Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. , 2011, American journal of respiratory and critical care medicine.

[119]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[120]  J. Kolls,et al.  Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production. , 2011, The Journal of allergy and clinical immunology.

[121]  M. Braga,et al.  Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer , 2011, The Journal of experimental medicine.

[122]  F. Muchemwa,et al.  Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-δ in normal human dermal fibroblasts. , 2011, The Journal of investigative dermatology.

[123]  R. Toes,et al.  Anti-citrullinated protein antibodies in rheumatoid arthritis: a functional role for mast cells and basophils? , 2011, Annals of the rheumatic diseases.

[124]  F. Finkelman,et al.  Interleukin-13 (IL-13)/IL-13 Receptor α1 (IL-13Rα1) Signaling Regulates Intestinal Epithelial Cystic Fibrosis Transmembrane Conductance Regulator Channel-dependent Cl− Secretion* , 2011, The Journal of Biological Chemistry.

[125]  M. Shields,et al.  Effects of IL-13 on Mucociliary Differentiation of Pediatric Asthmatic Bronchial Epithelial Cells , 2011, Pediatric Research.

[126]  Glenn C. Simon,et al.  Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherence. , 2011, American journal of respiratory cell and molecular biology.

[127]  T. Satoh,et al.  Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis , 2011, Allergy.

[128]  K. Fukuda,et al.  Synergistic induction of eotaxin and VCAM-1 expression in human corneal fibroblasts by staphylococcal peptidoglycan and either IL-4 or IL-13. , 2011, Allergology international : official journal of the Japanese Society of Allergology.

[129]  S. Fujieda,et al.  Interleukin-19 downregulates interleukin-4-induced eotaxin production in human nasal fibroblasts. , 2011, Allergology international : official journal of the Japanese Society of Allergology.

[130]  R. Locksley,et al.  IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity , 2010, Proceedings of the National Academy of Sciences.

[131]  H. Boushey,et al.  Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. , 2010, American journal of respiratory cell and molecular biology.

[132]  T. Wynn,et al.  Critical Role of IL-25 in Nematode Infection-Induced Alterations in Intestinal Function , 2010, The Journal of Immunology.

[133]  B. Laxman,et al.  Expression of IL-4/IL-13 receptors in differentiating human airway epithelial cells. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[134]  R. Pelanda,et al.  This information is current as Signaling Transitional B Cells following Tonic BCR Differentiation of Immature B Cells into BAFF Receptor Signaling Aids the , 2010 .

[135]  Florence Demenais,et al.  A large-scale, consortium-based genomewide association study of asthma. , 2010, The New England journal of medicine.

[136]  S. Oh,et al.  Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.

[137]  P. Cooper,et al.  Involvement of IL-13 in tobacco smoke-induced changes in the structure and function of rat intrapulmonary airways. , 2010, American journal of respiratory cell and molecular biology.

[138]  T. Hackett,et al.  IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. , 2010, The Journal of allergy and clinical immunology.

[139]  C. Brightling,et al.  Expression and activation of the oxytocin receptor in airway smooth muscle cells: Regulation by TNFα and IL-13 , 2010, Respiratory research.

[140]  L. Schon,et al.  Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes , 2010, Fibrogenesis & tissue repair.

[141]  B. Chiang,et al.  Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients , 2010, Lupus.

[142]  B. Diamond,et al.  Activated basophils give lupus a booster shot , 2010, Nature Medicine.

[143]  G. Illei,et al.  BASOPHILS AND THE T HELPER 2 ENVIRONMENT CAN PROMOTE THE DEVELOPMENT OF LUPUS NEPHRITIS , 2010, Nature Medicine.

[144]  D. Postma,et al.  Interleukin 13 and Interleukin 4 Receptor-α Polymorphisms in Rhinitis and Asthma , 2010, International Archives of Allergy and Immunology.

[145]  Eva Herrmann,et al.  Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. , 2010, Cytokine.

[146]  M. Solon,et al.  Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. , 2010, Journal of Allergy and Clinical Immunology.

[147]  D. Corry,et al.  Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease , 2010, Journal of Allergy and Clinical Immunology.

[148]  Sally E Wenzel,et al.  A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. , 2010, American journal of respiratory and critical care medicine.

[149]  C. Fiocchi,et al.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis , 2010, Proceedings of the National Academy of Sciences.

[150]  M. Kaplan,et al.  IL-4 Regulates Skin Homeostasis and the Predisposition toward Allergic Skin Inflammation , 2010, The Journal of Immunology.

[151]  K. Garcia,et al.  Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. , 2010, Structure.

[152]  E. B. Getz,et al.  Inhaled vs subcutaneous effects of a dual IL‐4/IL‐13 antagonist in a monkey model of asthma , 2010, Allergy.

[153]  L. Cosmi,et al.  Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. , 2010, The Journal of allergy and clinical immunology.

[154]  F. Finkelman,et al.  IL-13Rα2 Membrane and Soluble Isoforms Differ in Humans and Mice1 , 2009, The Journal of Immunology.

[155]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[156]  H. Simon,et al.  Natural killer T cells expressing IFN‐γ and IL‐4 in lesional skin of atopic eczema , 2009, Allergy.

[157]  J. Curtis,et al.  Elastase- and LPS-exposed mice display altered responses to rhinovirus infection. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[158]  R. Katoh,et al.  Thymic stromal lymphopoietin is a critical mediator of IL‐13‐driven allergic inflammation , 2009, European journal of immunology.

[159]  P. Allavena,et al.  Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation , 2009, Journal of leukocyte biology.

[160]  J. Ennaciri,et al.  IL-4Rα, a New Member that Associates with Syk Kinase: Implication in IL-4-Induced Human Neutrophil Functions1 , 2009, The Journal of Immunology.

[161]  S. Nishimura.  Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. , 2009, The American journal of pathology.

[162]  T. Chiba,et al.  Proinflammatory Th2 Cytokines Induce Production of Thymic Stromal Lymphopoietin in Human Colonic Epithelial Cells , 2009, Digestive Diseases and Sciences.

[163]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[164]  W. Strober,et al.  The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance. , 2009, Current molecular medicine.

[165]  S. Dooley,et al.  The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin‐13 as driving forces in fibrogenesis , 2009, Hepatology.

[166]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[167]  S. Hillier,et al.  Regulation of 3beta-hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines. , 2009, Molecular human reproduction.

[168]  E. Gabazza,et al.  IL‐4/IL‐13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis , 2009, The British journal of dermatology.

[169]  R. Medzhitov,et al.  Basophils Function as Antigen Presenting Cells for an Allergen-Induced TH2 Response , 2009, Nature Immunology.

[170]  J. Schroeder,et al.  Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. , 2009, The Journal of investigative dermatology.

[171]  J. Schröder,et al.  The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. , 2009, The Journal of investigative dermatology.

[172]  Sang-Heon Cho,et al.  Genetic variation of IL13 as a risk factor of reduced lung function in children and adolescents: a cross-sectional population-based study in Korea. , 2009, Respiratory medicine.

[173]  H. Sakai,et al.  Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein. , 2009, American journal of respiratory cell and molecular biology.

[174]  W. Ahn,et al.  Topical delivery of interleukin‐13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis , 2009, The journal of gene medicine.

[175]  P. Weller,et al.  Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially , 2008, Journal of leukocyte biology.

[176]  J. Ring,et al.  IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. , 2009, The Journal of allergy and clinical immunology.

[177]  J. Schulzke,et al.  Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function , 2008, Mucosal Immunology.

[178]  R. Puri,et al.  Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model , 2008, The Journal of Immunology.

[179]  I. Pavord,et al.  Induced sputum and bronchial mucosal expression of interleukin‐13 is not increased in chronic obstructive pulmonary disease , 2008, Allergy.

[180]  J. Redzic,et al.  Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. , 2008, The Journal of investigative dermatology.

[181]  N. Tzanakis,et al.  Tc2 response at the onset of COPD exacerbations. , 2008, Chest.

[182]  Joanna M. Roberts,et al.  In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation , 2008, Proceedings of the National Academy of Sciences.

[183]  G. Georgakis,et al.  Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. , 2008, Blood.

[184]  S. Treistman,et al.  Interleukin‐4 activates large‐conductance, calcium‐activated potassium (BKCa) channels in human airway smooth muscle cells , 2008, Experimental physiology.

[185]  Y. Talke,et al.  Basophils enhance immunological memory responses , 2008, Nature Immunology.

[186]  S. Wenzel,et al.  IL‐13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[187]  A. Bree,et al.  Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys , 2008, Journal of Pharmacology and Experimental Therapeutics.

[188]  Jeffrey D. Morton,et al.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease , 2008, Nature Medicine.

[189]  F. Finkelman,et al.  Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis , 2008, Proceedings of the National Academy of Sciences.

[190]  T. Gambichler,et al.  Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy , 2008, The British journal of dermatology.

[191]  L. Hofbauer,et al.  Interleukin‐4 and Interleukin‐13 Stimulate the Osteoclast Inhibitor Osteoprotegerin by Human Endothelial Cells Through the STAT6 Pathway , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[192]  E. Green,et al.  Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease1 , 2008, The Journal of Immunology.

[193]  M. Kasaian,et al.  A novel and sensitive ELISA reveals that the soluble form of IL‐13R‐α2 is not expressed in plasma of healthy or asthmatic subjects , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[194]  W. Luttmann,et al.  Interleukin‐13 acts as an apoptotic effector on lung epithelial cells and induces pro‐fibrotic gene expression in lung fibroblasts , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[195]  I. Pavord,et al.  Increased sputum and bronchial biopsy IL-13 expression in severe asthma. , 2008, The Journal of allergy and clinical immunology.

[196]  A. Murphy,et al.  Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chain , 2008, Nature Immunology.

[197]  S. Allahverdian,et al.  Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. , 2008, American journal of respiratory cell and molecular biology.

[198]  K. Christopher Garcia,et al.  Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System , 2008, Cell.

[199]  R. Homer,et al.  IL-13 Receptor α2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung1 , 2008, The Journal of Immunology.

[200]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[201]  M. Wittmann,et al.  Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation. , 2008, The Journal of investigative dermatology.

[202]  H. Williams,et al.  What are the best outcome measurements for atopic eczema? A systematic review. , 2007, The Journal of allergy and clinical immunology.

[203]  Todor A Popov,et al.  Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN , 2007, Allergy.

[204]  S. Wenzel,et al.  Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies , 2007, The Lancet.

[205]  E. Bleecker,et al.  IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function. , 2007, American journal of respiratory and critical care medicine.

[206]  Yee Hwa Yang,et al.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids , 2007, Proceedings of the National Academy of Sciences.

[207]  M. Aurrand-Lions,et al.  Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. , 2007, Arthritis and rheumatism.

[208]  Jessica M. McMurray,et al.  Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study , 2007, Respiratory research.

[209]  B. Chang,et al.  Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. , 2007, The Journal of allergy and clinical immunology.

[210]  H. Itoh,et al.  Interleukin-13 stimulates the secretion of vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 by human oviductal epithelial cells. , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[211]  I. Sayers,et al.  Genetic association studies of interleukin-13 receptor α1 subunit gene polymorphisms in asthma and atopy , 2007, European Respiratory Journal.

[212]  D. DeMeo,et al.  Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood. , 2007, The Journal of allergy and clinical immunology.

[213]  D. Radisky,et al.  Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT? , 2007, Journal of cellular biochemistry.

[214]  K. Barnes,et al.  Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2007, The Journal of allergy and clinical immunology.

[215]  J. Auwerx,et al.  IL‐13 induces expression of CD36 in human monocytes through PPARγ activation , 2007, European journal of immunology.

[216]  T. Kimman,et al.  IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. , 2007, The Journal of allergy and clinical immunology.

[217]  Y. H. Yang,et al.  Higher Bcl‐2 levels decrease staphylococcal superantigen‐induced apoptosis of CD4+ T cells in atopic dermatitis , 2007, Allergy.

[218]  I. Pavord,et al.  Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial , 2007, European Respiratory Journal.

[219]  M. Pelletier,et al.  Molecular mechanisms involved in interleukin‐4‐induced human neutrophils: expression and regulation of suppressor of cytokine signaling , 2007, Journal of leukocyte biology.

[220]  A. Bree,et al.  IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. , 2007, The Journal of allergy and clinical immunology.

[221]  I. Dusanter-Fourt,et al.  Interleukin‐4 induces human hepatocyte apoptosis through a Fas‐independent pathway , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[222]  R. Ravazzolo,et al.  Thiocyanate Transport in Resting and IL-4-Stimulated Human Bronchial Epithelial Cells: Role of Pendrin and Anion Channels1 , 2007, The Journal of Immunology.

[223]  B. Levy,et al.  Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. , 2007, American journal of respiratory cell and molecular biology.

[224]  C. Günther,et al.  CCL23 Expression Is Induced by IL-4 in a STAT6-Dependent Fashion , 2007, The Journal of Immunology.

[225]  D. Curran‐Everett,et al.  IL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression , 2007 .

[226]  X. Sastre,et al.  Cutting Edge: Proinflammatory and Th2 Cytokines Synergize to Induce Thymic Stromal Lymphopoietin Production by Human Skin Keratinocytes1 , 2007, The Journal of Immunology.

[227]  V. Suresh,et al.  Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. , 2007, American journal of respiratory cell and molecular biology.

[228]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[229]  Anthony Asher,et al.  Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma , 2003, Journal of Neuro-Oncology.

[230]  R. Fuller,et al.  Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic eczema , 2007 .

[231]  M. Halonen,et al.  Th2 Cell-Selective Enhancement of Human IL13 Transcription by IL13-1112C>T, a Polymorphism Associated with Allergic Inflammation1 , 2006, The Journal of Immunology.

[232]  E. Gelfand,et al.  IL-13 is essential to the late-phase response in allergic rhinitis. , 2006, The Journal of allergy and clinical immunology.

[233]  C. Bachert,et al.  Differentiation of chronic sinus diseases by measurement of inflammatory mediators , 2006, Allergy.

[234]  A. Bosio,et al.  Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. , 2006, The Journal of allergy and clinical immunology.

[235]  A. Agustí,et al.  Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease , 2006, Clinical and experimental immunology.

[236]  L. Jones,et al.  Severe atopic dermatitis is associated with a reduced frequency of IL‐10 producing allergen‐specific CD4+ T cells , 2006, Clinical and experimental dermatology.

[237]  C. Brightling,et al.  Mast cells express IL‐13Rα1: IL‐13 promotes human lung mast cell proliferation and FcɛRI expression , 2006, Allergy.

[238]  J. Berzofsky,et al.  Intratumoral Therapy with IL13-PE38 Results in Effective CTL-Mediated Suppression of IL-13Rα2-Expressing Contralateral Tumors , 2006, Clinical Cancer Research.

[239]  J. Gaudart,et al.  Evaluation of interleukin 13 polymorphisms in systemic sclerosis , 2006, Immunogenetics.

[240]  Terry J. Smith,et al.  Interleukin-4 Induces 15-Lipoxygenase-1 Expression in Human Orbital Fibroblasts from Patients with Graves Disease , 2006, Journal of Biological Chemistry.

[241]  L. Teran,et al.  CC chemokine ligand 1 is released into the airways of atopic asthmatics , 2006, European Respiratory Journal.

[242]  S. Toda,et al.  Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. , 2006, The Journal of allergy and clinical immunology.

[243]  C. Wong,et al.  Interleukin (IL)‐4 and IL‐13 up‐regulate monocyte chemoattractant protein‐1 expression in human bronchial epithelial cells: involvement of p38 mitogen‐activated protein kinase, extracellular signal‐regulated kinase 1/2 and Janus kinase‐2 but not c‐Jun NH2‐terminal kinase 1/2 signalling pathways , 2006, Clinical and experimental immunology.

[244]  S. Peters,et al.  Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. , 2006, Respiratory medicine.

[245]  S. Wenzel,et al.  Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. , 2006, The Journal of allergy and clinical immunology.

[246]  Thomas Werfel,et al.  IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. , 2006, The Journal of investigative dermatology.

[247]  A. Magnan,et al.  Diesel exhaust particles enhance T‐cell activation in severe asthmatics , 2006, Allergy.

[248]  G. Berry,et al.  CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.

[249]  James F. Jones,et al.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. , 2006, Immunity.

[250]  A. Dvorak,et al.  Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[251]  S. Weiland,et al.  IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. , 2006, The Journal of allergy and clinical immunology.

[252]  R. Panettieri,et al.  Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype. , 2006, American journal of respiratory cell and molecular biology.

[253]  C. Akdis,et al.  Absence of T-regulatory cell expression and function in atopic dermatitis skin. , 2006, The Journal of allergy and clinical immunology.

[254]  K. Wolff,et al.  Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice , 2006, American journal of clinical dermatology.

[255]  D. Groneberg,et al.  Parental tobacco smoking is associated with augmented IL-13 secretion in children with allergic asthma. , 2006, The Journal of allergy and clinical immunology.

[256]  R. Puri,et al.  IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis , 2006, Nature Medicine.

[257]  S. Durham,et al.  Single dose topical corticosteroid inhibits IL‐5 and IL‐13 in nasal lavage following grass pollen challenge , 2005, Allergy.

[258]  F. Lund,et al.  Cutting Edge: The Development of IL-4-Producing B Cells (B Effector 2 Cells) Is Controlled by IL-4, IL-4 Receptor α, and Th2 Cells1 , 2005, The Journal of Immunology.

[259]  S. Yamamoto,et al.  dsRNA enhances eotaxin-3 production through interleukin-4 receptor upregulation in airway epithelial cells , 2005, European Respiratory Journal.

[260]  T. Deutschle,et al.  Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls , 2005, Allergy.

[261]  N. Pedemonte,et al.  Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways. , 2005, American journal of respiratory and critical care medicine.

[262]  A. Dvorak,et al.  Human Eosinophils Secrete Preformed, Granule‐Stored Interleukin‐4 Through Distinct Vesicular Compartments , 2005, Traffic.

[263]  Onofrio Resta,et al.  Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma. , 2005, European journal of pharmacology.

[264]  Koichiro Nakamura,et al.  Interleukin‐4 and interleukin‐13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells , 2005, Clinical and experimental immunology.

[265]  Q. Hamid,et al.  Human Airway Smooth Muscle Cells Express the High Affinity Receptor for IgE (FcεRI): A Critical Role of FcεRI in Human Airway Smooth Muscle Cell Function , 2005, The Journal of Immunology.

[266]  P. Gibson,et al.  Interleukin-10 gene expression in acute virus-induced asthma. , 2005, American journal of respiratory and critical care medicine.

[267]  M. Zeitz,et al.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.

[268]  P. Sly,et al.  Lyn-Deficient Mice Develop Severe, Persistent Asthma: Lyn Is a Critical Negative Regulator of Th2 Immunity 1 , 2005, The Journal of Immunology.

[269]  M. Wani,et al.  IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-κB and Ca2+ Signaling1 , 2005, The Journal of Immunology.

[270]  N. Papadopoulos,et al.  IL-4 increases type 2, but not type 1, cytokine production in CD8+ T cells from mild atopic asthmatics , 2005, Respiratory Research.

[271]  L. Jones,et al.  Interleukin‐4 induced down‐regulation of skin homing receptor expression by human viral‐specific CD8+ T cells may contribute to atopic risk of cutaneous infection , 2005, Clinical and experimental immunology.

[272]  J. Lieberman,et al.  Vaccinia Virus Induces Strong Immunoregulatory Cytokine Production in Healthy Human Epidermal Keratinocytes: a Novel Strategy for Immune Evasion , 2005, Journal of Virology.

[273]  N. Schoof,et al.  STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis , 2005, Leukemia.

[274]  Klas Svensson,et al.  Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.

[275]  N. Siafakas,et al.  Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. , 2005, Respiratory medicine.

[276]  K. Kotoh,et al.  Effect of IL‐4 and IL‐13 on collagen production in cultured LI90 human hepatic stellate cells , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[277]  R. Sun,et al.  Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. , 2005, The Journal of allergy and clinical immunology.

[278]  E. Nemoto,et al.  Expression of CD13/aminopeptidase N on human gingival fibroblasts and up-regulation upon stimulation with interleukin-4 and interleukin-13. , 2005, Journal of periodontal research.

[279]  M. Lynch,et al.  Role of Interleukin-4 in Regulation of Age-related Inflammatory Changes in the Hippocampus* , 2005, Journal of Biological Chemistry.

[280]  Matthew R. Jones,et al.  Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13. , 2005, The Journal of allergy and clinical immunology.

[281]  G. Passalacqua,et al.  CD4+IL‐13+ cells in peripheral blood well correlates with the severity of atopic dermatitis in children , 2005, Allergy.

[282]  D. Vercelli,et al.  IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. , 2005, The Journal of clinical investigation.

[283]  M. Kornmann,et al.  Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions , 2005, British Journal of Cancer.

[284]  F. Finkelman,et al.  Interleukin‐4‐ and interleukin‐13‐mediated host protection against intestinal nematode parasites , 2004, Immunological reviews.

[285]  Bing Sun,et al.  Cultured human endometrial epithelial cells produce thymus and activation-regulated chemokine with stimulation of interleukin-4 and interleukin-13. , 2004, Fertility and sterility.

[286]  H. Simon,et al.  Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment. , 2004, The Journal of allergy and clinical immunology.

[287]  M. Jinnin,et al.  Interleukin-13 Stimulates the Transcription of the Human α2(I) Collagen Gene in Human Dermal Fibroblasts* , 2004, Journal of Biological Chemistry.

[288]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[289]  L. Wakefield,et al.  IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent , 2004, The Journal of Immunology.

[290]  G. K. Khurana Hershey,et al.  Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. , 2004, The Journal of allergy and clinical immunology.

[291]  Q. Hamid,et al.  Synthesis of IL-13 by human B lymphocytes: regulation and role in IgE production. , 2004, The Journal of allergy and clinical immunology.

[292]  Shau-ku Huang,et al.  Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. , 2004, American journal of respiratory cell and molecular biology.

[293]  R. Flavell,et al.  Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma. , 2004, International immunology.

[294]  T. Wynn.  Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[295]  M. Babina,et al.  Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells , 2004, Archives of Dermatological Research.

[296]  Steven M. Miller,et al.  Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. , 2004, American journal of respiratory cell and molecular biology.

[297]  M. Zaitsu,et al.  Upregulation of interleukin-4 receptor by interferon-gamma: enhanced interleukin-4-induced eotaxin-3 production in airway epithelium. , 2004, American journal of respiratory cell and molecular biology.

[298]  I. Biaggioni,et al.  Adenosine-Activated Mast Cells Induce IgE Synthesis by B Lymphocytes: An A2B-Mediated Process Involving Th2 Cytokines IL-4 and IL-13 with Implications for Asthma12 , 2004, The Journal of Immunology.

[299]  V. Giusti,et al.  Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. , 2004, The Journal of clinical endocrinology and metabolism.

[300]  P. Mannon,et al.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. , 2004, The Journal of clinical investigation.

[301]  S. Trudel,et al.  Soluble Interleukin-13Rα2 Decoy Receptor Inhibits Hodgkin’s Lymphoma Growth in Vitro and in Vivo , 2004 .

[302]  R. Pawankar,et al.  Induction of eotaxin production by interleukin‐4, interleukin‐13 and lipopolysaccharide by nasal fibroblasts , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[303]  Seung-Up Kim,et al.  Microglia expressing interleukin‐13 undergo cell death and contribute to neuronal survival in vivo , 2004, Glia.

[304]  H. Sugiura,et al.  Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis , 2004, Archives of Dermatological Research.

[305]  A. Musani,et al.  Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)‐β1, TGF‐β2, interleukin (IL)‐4 and IL‐13 after segmental allergen challenge and their effects on α‐smooth muscle actin and collagen III synthesis by primary human lung fibroblasts , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[306]  L. Borish,et al.  Inhibition of effector T lymphocytes mediated through antagonism of IL-4. , 2004, The Journal of allergy and clinical immunology.

[307]  D. Romberger,et al.  IL-4 and IL-13 Stimulate Human Bronchial Epithelial Cells to Release IL-8 , 1999, Inflammation.

[308]  M. Furue,et al.  Reciprocal regulation of thymus and activation-regulated chemokine/macrophage-derived chemokine production by interleukin (IL)-4/IL-13 and interferon-gamma in HaCaT keratinocytes is mediated by alternations in E-cadherin distribution. , 2004, The Journal of investigative dermatology.

[309]  N. Otori,et al.  TNF-α and IL-4 regulate expression of IL-13 receptor α2 on human fibroblasts , 2003 .

[310]  R. Panettieri,et al.  IL‐13 enhances agonist‐evoked calcium signals and contractile responses in airway smooth muscle , 2003, British journal of pharmacology.

[311]  T. Wynn.  IL-13 effector functions. , 2003, Annual review of immunology.

[312]  T. Sandström,et al.  Repeated daily exposure to 2 ppm nitrogen dioxide upregulates the expression of IL-5, IL-10, IL-13, and ICAM-1 in the bronchial epithelium of healthy human airways , 2003, Occupational and environmental medicine.

[313]  H. Suto,et al.  Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. , 2003, Journal of dermatological science.

[314]  T. Kurz,et al.  Association study of the IL13 variant Arg110Gln in atopic diseases and juvenile idiopathic arthritis. , 2003, The Journal of allergy and clinical immunology.

[315]  R. Panettieri,et al.  IL-13 and IL-4 promote TARC release in human airway smooth muscle cells: role of IL-4 receptor genotype. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[316]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[317]  S. Cuvelier,et al.  IL‐4 primes human endothelial cells for secondary responses to histamine , 2003, Journal of leukocyte biology.

[318]  H. Danahay,et al.  IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[319]  T. Beaty,et al.  Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. , 2003, The Journal of allergy and clinical immunology.

[320]  A. Keegan,et al.  IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. , 2003, Blood.

[321]  Su‐Li Cheng,et al.  IL‐13 regulates vascular cell adhesion molecule‐1 expression in human osteoblasts , 2003, Journal of cellular biochemistry.

[322]  R. Hirschberg,et al.  BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells , 2003 .

[323]  T. Fukuda,et al.  Up-Regulation of Cysteinyl Leukotriene 1 Receptor by IL-13 Enables Human Lung Fibroblasts to Respond to Leukotriene C4 and Produce Eotaxin , 2003, The Journal of Immunology.

[324]  N. Anthonisen,et al.  Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers. , 2003, American journal of respiratory cell and molecular biology.

[325]  I. Bellinghausen,et al.  Production of interleukin‐13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription‐6 , 2003, Immunology.

[326]  M. Mack,et al.  Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease , 2003, Nature Medicine.

[327]  Yong Woo Lee,et al.  Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells. , 2003, American journal of physiology. Heart and circulatory physiology.

[328]  J. Fahy.  Goblet cell and mucin gene abnormalities in asthma. , 2002, Chest.

[329]  A. Mintz,et al.  Alanine-scanning Mutagenesis of α-Helix D Segment of Interleukin-13 Reveals New Functionally Important Residues of the Cytokine* , 2002, The Journal of Biological Chemistry.

[330]  Koichiro Nakamura,et al.  Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. , 2002, Journal of dermatological science.

[331]  S. Wenzel,et al.  TGF-β and IL-13 Synergistically Increase Eotaxin-1 Production in Human Airway Fibroblasts1 , 2002, The Journal of Immunology.

[332]  K. Urabe,et al.  Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-13, TNF-α and IFN-γ in human keratinocyte and fibroblast , 2002 .

[333]  M. Burdick,et al.  Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. , 2002, American journal of respiratory cell and molecular biology.

[334]  M. Brigham-Burke,et al.  Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti‐interleukin‐4 antibody with therapeutic potential in asthma , 2002, Clinical and experimental immunology.

[335]  Paige Lacy,et al.  Human eosinophils express and release IL‐13 following CD28‐dependent activation , 2002, Journal of leukocyte biology.

[336]  K. Arai,et al.  Analysis of novel disease-related genes in bronchial asthma. , 2002, Cytokine.

[337]  B. Ma,et al.  Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. , 2002, The Journal of clinical investigation.

[338]  Jonathan A. Bernstein,et al.  V75R576 IL-4 Receptor α Is Associated with Allergic Asthma and Enhanced IL-4 Receptor Function1 , 2002, The Journal of Immunology.

[339]  D. Sheppard,et al.  Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma , 2002, Nature Medicine.

[340]  C. Ra,et al.  T Cells and Mast Cells as a Major Source of Interleukin-13 in Atopic Dermatitis , 2002, Dermatology.

[341]  C. Bizer,et al.  Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases1 , 2002, The Journal of Immunology.

[342]  Chunfeng Ma,et al.  Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion. , 2002, Journal of reproductive immunology.

[343]  M. Pembrey,et al.  An interaction between the IL‐4Rα gene and infection is associated with atopic eczema in young children , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[344]  Susan J Wilson,et al.  Cooperative Effects of Th2 Cytokines and Allergen on Normal and Asthmatic Bronchial Epithelial Cells1 , 2002, The Journal of Immunology.

[345]  T. Mak,et al.  The role of cytokines in classical Hodgkin lymphoma. , 2002, Blood.

[346]  R. Puri,et al.  Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. , 2002, The Journal of allergy and clinical immunology.

[347]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[348]  P. Barnes,et al.  Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. , 2002, American journal of respiratory and critical care medicine.

[349]  Tak H. Lee,et al.  Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. , 2002, American journal of respiratory and critical care medicine.

[350]  N. Papadopoulos,et al.  A defective type 1 response to rhinovirus in atopic asthma , 2002, Thorax.

[351]  R. Panettieri,et al.  IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[352]  S. Rennard,et al.  Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. , 2002, American journal of respiratory cell and molecular biology.

[353]  G. Hershey,et al.  A Novel Mechanism by Which Interferon-γ Can Regulate Interleukin (IL)-13 Responses , 2002, The Journal of Biological Chemistry.

[354]  H. Danahay,et al.  Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[355]  T. Mak,et al.  The Role of Interleukin 13 in Classical Hodgkin Lymphoma , 2002, Leukemia & lymphoma.

[356]  D. Postma,et al.  Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. , 2002, American journal of human genetics.

[357]  E. Wouters,et al.  Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism , 2002, Genes and Immunity.

[358]  R. Pauwels,et al.  Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells. , 2001, American journal of respiratory and critical care medicine.

[359]  A Coste,et al.  IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. , 2001, The Journal of clinical investigation.

[360]  L. Martin,et al.  Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. , 2001, American journal of respiratory cell and molecular biology.

[361]  E. Pearce,et al.  Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.

[362]  D. Umetsu,et al.  Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity1 , 2001, The Journal of Immunology.

[363]  Luting Xu,et al.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. , 2001, The Journal of investigative dermatology.

[364]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[365]  N. Thomson,et al.  Immuno‐regulatory cytokines in asthma: IL‐15 and IL‐13 in induced sputum , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[366]  D. Postma,et al.  Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. , 2001, American journal of respiratory cell and molecular biology.

[367]  R. Djukanović,et al.  The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. , 2001, American journal of respiratory cell and molecular biology.

[368]  J. Stankova,et al.  IL-13 and IL-4 Up-Regulate Cysteinyl Leukotriene 1 Receptor Expression in Human Monocytes and Macrophages1 , 2001, The Journal of Immunology.

[369]  K. Lindblad-Toh,et al.  A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma. , 2001, Genomics.

[370]  J. Kinet,et al.  Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. , 2001, American Journal of Respiratory and Critical Care Medicine.

[371]  W. Busse,et al.  Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. , 2001, The Journal of allergy and clinical immunology.

[372]  H. Nakagawa,et al.  Interferon-Gamma-Induced RANTES Production by Human Keratinocytes Is Enhanced by IL-1β, TNF-α, IL-4 and IL-13 and Is Inhibited by Dexamethasone and Tacrolimus , 2001, Dermatology.

[373]  J. C. Pratt,et al.  A Murine IL-4 Receptor Antagonist That Inhibits IL-4- and IL-13-Induced Responses Prevents Antigen-Induced Airway Eosinophilia and Airway Hyperresponsiveness1 , 2001, The Journal of Immunology.

[374]  E. Gelfand,et al.  Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. , 2001, The Journal of investigative dermatology.

[375]  R. Puri,et al.  The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. , 2001, Blood.

[376]  L. J. Woods,et al.  Cutting Edge: Eotaxin Elicits Rapid Vesicular Transport-Mediated Release of Preformed IL-4 from Human Eosinophils1 , 2001, The Journal of Immunology.

[377]  J. Westwick,et al.  Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma1 , 2001, The Journal of Immunology.

[378]  M. Kraft,et al.  IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. , 2001, The Journal of allergy and clinical immunology.

[379]  D. Edwards,et al.  TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. , 2001, Journal of the American Society of Nephrology : JASN.

[380]  T. Shimoda,et al.  Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[381]  S. Ljunghall,et al.  Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha. , 2001, Bone.

[382]  D. Togninalli,et al.  IL-4 and IL-13, But Not IL-10, Protect Human Synoviocytes from Apoptosis1 , 2001, The Journal of Immunology.

[383]  W. Khan,et al.  Critical Role for Signal Transducer and Activator of Transcription Factor 6 in Mediating Intestinal Muscle Hypercontractility and Worm Expulsion in Trichinella spiralis-Infected Mice , 2001, Infection and Immunity.

[384]  R. Gascoyne,et al.  Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. , 2001, Blood.

[385]  V. Casolaro,et al.  Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. , 2001, American journal of respiratory cell and molecular biology.

[386]  M. Grusby,et al.  Cutting Edge: STAT6-Deficient Mice Have Enhanced Tumor Immunity to Primary and Metastatic Mammary Carcinoma1 , 2000, The Journal of Immunology.

[387]  S. Wenzel,et al.  Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. , 2000, The Journal of allergy and clinical immunology.

[388]  Jay A. Berzofsky,et al.  NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway , 2000, Nature Immunology.

[389]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[390]  John C. Lee,et al.  SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[391]  M. Capron,et al.  IL‐4 production by human polymorphonuclear neutrophils , 2000, Journal of leukocyte biology.

[392]  U. Wahn,et al.  An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). , 2000, The Journal of allergy and clinical immunology.

[393]  P. Allavena,et al.  Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes1 , 2000, The Journal of Immunology.

[394]  Hirai,et al.  Interleukin‐13 and tumour necrosis factor‐α synergistically induce eotaxin production in human nasal fibroblasts , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[395]  K. Deichmann,et al.  Genetic variants of IL-13 signalling and human asthma and atopy. , 2000, Human molecular genetics.

[396]  K. Ihara,et al.  Novel Polymorphism in the Coding Region of the IL-13 Receptor Alpha’ Gene: Association Study with Atopic Asthma in the Japanese Population , 2000, Experimental and Clinical Immunogenetics.

[397]  W. Henderson,et al.  Soluble IL-4 Receptor Inhibits Airway Inflammation Following Allergen Challenge in a Mouse Model of Asthma1 , 2000, The Journal of Immunology.

[398]  B Vyas,et al.  Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. , 2000, Blood.

[399]  L. Borish,et al.  Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. , 1999, American journal of respiratory and critical care medicine.

[400]  K. Deichmann,et al.  Characterization of the membrane-bound and a soluble form of human IL-4 receptor alpha produced by alternative splicing. , 1999, International immunology.

[401]  C. Akdis,et al.  T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. , 1999, The Journal of investigative dermatology.

[402]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[403]  E. Silverman,et al.  Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. , 1999, American journal of respiratory and critical care medicine.

[404]  E. Groot,et al.  An IL-13 promoter polymorphism associated with increased risk of allergic asthma , 1999, Genes and Immunity.

[405]  J Zhang,et al.  What are minimal important changes for asthma measures in a clinical trial? , 1999, The European respiratory journal.

[406]  K. Dabbagh,et al.  IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. , 1999, Journal of immunology.

[407]  D. Salter,et al.  Integrin-regulated Secretion of Interleukin 4: A Novel Pathway of Mechanotransduction in Human Articular Chondrocytes , 1999, The Journal of cell biology.

[408]  K. thestrup-pedersen,et al.  Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. , 1999, Journal of immunology.

[409]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[410]  K. Wagner,et al.  Enhancement of human IL‐4 activity by soluble IL‐4 receptors in vitro , 1999, European journal of immunology.

[411]  Sparholt,et al.  The polymorphisms S503P and Q576R in the interleukin‐4 receptor α gene are associated with atopy and influence the signal transduction , 1999, Immunology.

[412]  W. Luttmann,et al.  Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro. , 1999, American journal of respiratory cell and molecular biology.

[413]  C. Gabay,et al.  Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. , 1999, Blood.

[414]  K. Tadokoro,et al.  Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells. , 1999, Experimental hematology.

[415]  H. Young,et al.  IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. , 1999, Journal of immunology.

[416]  P. Linsley,et al.  B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. , 1999, American journal of respiratory cell and molecular biology.

[417]  M. Cybulsky,et al.  Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. , 1999, International immunology.

[418]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[419]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[420]  M. Rihanek,et al.  STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. , 1998, Journal of immunology.

[421]  J. Southgate,et al.  Interleukins 4 and 13 upregulate expression of cd44 in human colonic epithelial cell lines. , 1998, Cytokine.

[422]  R. Pawankar,et al.  Production of IL-13 by human lung mast cells in response to Fcepsilon receptor cross-linkage. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[423]  H. Hoogsteden,et al.  Interleukin 4 receptors on human bronchial epithelial cells. An in vivo and in vitro analysis of expression and function. , 1998, Cytokine.

[424]  C. Bruijnzeel-Koomen,et al.  Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. , 1998, American journal of respiratory cell and molecular biology.

[425]  G. Rice,et al.  Immunolocalisation of Interleukin-4 and Interleukin-4 Receptor in Placenta and Fetal Membranes in Association with Pre-Term Labour and Pre-Eclampsia , 1998, Gynecologic and Obstetric Investigation.

[426]  C. Ohlsson,et al.  Interleukin-13 inhibits cell proliferation and stimulates interleukin-6 formation in isolated human osteoblasts. , 1998, The Journal of clinical endocrinology and metabolism.

[427]  Bullens,et al.  Effects of anti‐IL‐4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL‐4 production by T cells from non‐atopic donors , 1998, Clinical and experimental immunology.

[428]  R. Pawankar,et al.  Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. , 1998, The Journal of allergy and clinical immunology.

[429]  K. Shirato,et al.  Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells. , 1998, The Journal of allergy and clinical immunology.

[430]  D. Wong,et al.  IL-4-Dependent Regulation of TGF-α and TGF-β1 Expression in Human Eosinophils , 1998, The Journal of Immunology.

[431]  Makiko Kobayashi,et al.  A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. , 1998, Journal of immunology.

[432]  H. Xu,et al.  Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. , 1998, American journal of respiratory and critical care medicine.

[433]  C. Serhan,et al.  Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release , 1998, The Journal of experimental medicine.

[434]  M. Wills-Karp,et al.  Signal Transducer and Activator of Transcription Factor 6 (Stat6)-deficient Mice Are Protected from Antigen-induced Airway Hyperresponsiveness and Mucus Production , 1998, The Journal of experimental medicine.

[435]  P. Sommer,et al.  Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[436]  N. Hamasaki,et al.  Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma , 1998, Nature Genetics.

[437]  A. Mallet,et al.  IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. , 1998, Journal of immunology.

[438]  T. Chatila,et al.  The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. , 1997, The New England journal of medicine.

[439]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[440]  C. Akdis,et al.  Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. , 1997, Journal of immunology.

[441]  B. Huber,et al.  Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IκBα , 1997 .

[442]  A. Roach,et al.  Chemokine production by human vascular smooth muscle cells: modulation by IL‐13 , 1997, British journal of pharmacology.

[443]  H. Sato,et al.  Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. , 1997, The Journal of rheumatology.

[444]  B. Williams,et al.  Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. , 1997, The Journal of clinical investigation.

[445]  M. Benson,et al.  Cytokines in nasal fluids from school children with seasonal allergic rhinitis , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[446]  E. Bröcker,et al.  Interleukin‐13 selectively induces monocyte chemoattractant protein‐1 synthesis and secretion by human endothelial cells. Involvement of IL‐4Rα and Stat6 phosphorylation , 1997, Immunology.

[447]  A. Beaulieu,et al.  Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. , 1997, The Biochemical journal.

[448]  S. Durham,et al.  IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. , 1997, American journal of respiratory cell and molecular biology.

[449]  S. Durham,et al.  Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. , 1997, The Journal of allergy and clinical immunology.

[450]  R. Pawankar,et al.  Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. , 1997, The Journal of clinical investigation.

[451]  R. Martin,et al.  Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. , 1997, American journal of respiratory and critical care medicine.

[452]  F. Finkelman,et al.  Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. , 1997, The American journal of physiology.

[453]  P. Ferrara,et al.  Cloning of the human IL‐13Rα1 chain and reconstitution with the IL‐4Rα of a functional IL‐4/IL‐13 receptor complex , 1997 .

[454]  C. Hart,et al.  Localization of IL‐4 and IL‐4 receptors in the human term placenta, decidua and amniochorionic membranes , 1997, Immunology.

[455]  S. Sone,et al.  Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. , 1996, American journal of respiratory cell and molecular biology.

[456]  C. Kroegel,et al.  Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. , 1996, The Journal of allergy and clinical immunology.

[457]  S. Durham,et al.  IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. , 1996, American journal of respiratory and critical care medicine.

[458]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[459]  S. Szefler,et al.  A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. , 1996, Journal of immunology.

[460]  T. Kotsimbos,et al.  Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. , 1996, Proceedings of the Association of American Physicians.

[461]  K. Chung,et al.  Interleukin 13 inhibits macrophage inflammatory protein-1 alpha production from human alveolar macrophages and monocytes. , 1996, American journal of respiratory cell and molecular biology.

[462]  W. Luttmann,et al.  Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. , 1996, Journal of immunology.

[463]  M. Tardieu,et al.  Interleukin-13 and interleukin-4 act as interleukin-6 inducers in human microglial cells. , 1996, Cytokine.

[464]  R. Djukanović,et al.  Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. , 1996, The European respiratory journal.

[465]  B. Stripp,et al.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[466]  A. Saxon,et al.  Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. , 1996, The Journal of allergy and clinical immunology.

[467]  E. Minshall,et al.  In vivo expression of IL-12 and IL-13 in atopic dermatitis. , 1996, The Journal of allergy and clinical immunology.

[468]  J. Pan,et al.  Interleukin 4 or oncostatin M induces a prolonged increase in P- selectin mRNA and protein in human endothelial cells , 1996, The Journal of experimental medicine.

[469]  R. Alam,et al.  IL-13 released by and localized in human basophils. , 1996, Journal of immunology.

[470]  B. Ryffel,et al.  Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. , 1996, Blood.

[471]  M. Schlaak,et al.  Human basophils release interleukin‐4 after stimulation with Schistosoma mansoni egg antigen , 1996, European journal of immunology.

[472]  W. Luttmann,et al.  Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. , 1996, The European respiratory journal.

[473]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[474]  M. Lovett,et al.  Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. , 1996, Blood.

[475]  S. Durham,et al.  Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. , 1996, American journal of respiratory and critical care medicine.

[476]  E. Gelfand,et al.  Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. , 1996, International archives of allergy and immunology.

[477]  S. Atamas,et al.  An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. , 1996, Journal of immunology.

[478]  Santa Jeremy Ono,et al.  Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. , 1996, Journal of immunology.

[479]  R. Locksley,et al.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.

[480]  K. Akiyama,et al.  Functional significance of IL-4 receptor on B cells in IL-4-induced human IgE production. , 1995, The Journal of allergy and clinical immunology.

[481]  T. Brunner,et al.  IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. , 1995, Blood.

[482]  S. Durham,et al.  Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. , 1995, Journal of immunology.

[483]  P. O'Byrne,et al.  Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. , 1995, Journal of immunology.

[484]  A. Saxon,et al.  IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass-specific isotype switch: switching to gamma 1, gamma 3, and gamma 4, but not gamma 2. , 1995, Journal of immunology.

[485]  L. Lichtenstein,et al.  IL-13 expression at the sites of allergen challenge in patients with asthma. , 1995, Journal of immunology.

[486]  G. Barnett,et al.  Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression , 1995, Journal of Neuroimmunology.

[487]  C. Bertrand,et al.  Interleukin-4 is required for the induction of lung Th2 mucosal immunity. , 1995, American journal of respiratory cell and molecular biology.

[488]  P. Allavena,et al.  IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. , 1995, European cytokine network.

[489]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[490]  S. Peters,et al.  sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. , 1995, American journal of respiratory and critical care medicine.

[491]  S. Durham,et al.  Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. , 1995, American journal of respiratory cell and molecular biology.

[492]  E. Frolova,et al.  Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. , 1995, Gene.

[493]  F. Mills,et al.  Activated mast cells produce interleukin 13 , 1995, The Journal of experimental medicine.

[494]  J. Pober,et al.  IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. , 1995, Journal of immunology.

[495]  J. Bousquet,et al.  Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma. , 1994, The Journal of allergy and clinical immunology.

[496]  R. Braun,et al.  Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.

[497]  A. Minty,et al.  Interleukin 13 is a B cell stimulating factor , 1994, The Journal of experimental medicine.

[498]  D. Largaespada,et al.  Structural comparison and chromosomal localization of the human and mouse IL-13 genes. , 1993, Journal of immunology.

[499]  R. de Waal Malefyt,et al.  Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[500]  P. Wernet,et al.  Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. , 1993, Experimental hematology.

[501]  P. Casellas,et al.  lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses , 1993, Nature.

[502]  J. Dayer,et al.  Regulation of Interleukin-1ra, Interleukin-1α, and Interleukin-1β Production by Human Alveolar Macrophages with Phorbol Myristate Acetate, Lipopolysaccharide, and Interleukin-4 , 1993 .

[503]  P. Howarth,et al.  Interleukin 4 is localized to and released by human mast cells , 1992, The Journal of experimental medicine.

[504]  M. Lovett,et al.  The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. , 1992, Nucleic acids research.

[505]  S. Sone,et al.  Differential effects of interleukin‐4 on superoxide anion production by human alveolar macrophages stimulated with lipopolysaccharide and interferon‐γ , 1992, Journal of leukocyte biology.

[506]  J. Dayer,et al.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.

[507]  P. Leder,et al.  A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. , 1992, The Journal of biological chemistry.

[508]  M. de Carli,et al.  Aberrant interleukin (IL)‐4 and IL‐5 production in vitro by CD4+ helper T cells from atopic subjects , 1992, European journal of immunology.

[509]  M. de Carli,et al.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. , 1992, Journal of immunology.

[510]  S. Sone,et al.  Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1. , 1992, The European respiratory journal.

[511]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[512]  W. Stetler-Stevenson,et al.  Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. , 1992, The Journal of biological chemistry.

[513]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[514]  J. Cavaillon,et al.  Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serumfree cultures of autologous monocytes , 1989, European journal of immunology.

[515]  P. Hart,et al.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[516]  I. G. Young,et al.  Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. , 1989, Blood.

[517]  F. Herrmann,et al.  Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes. , 1989, Blood.

[518]  L. Davis,et al.  Promotion of human T lymphocyte proliferation by IL-4. , 1989, Journal of immunology.

[519]  T. Mosmann,et al.  A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. , 1989, Journal of immunology.

[520]  L. Lanier,et al.  The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. , 1988, Journal of immunology.

[521]  J. Banchereau,et al.  IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. , 1988, Journal of immunology.

[522]  J. Bonnefoy,et al.  Interleukin 5 enhances interleukin 4‐induced IgE production by normal human B cells. The role of soluble CD23 antigen , 1988, European journal of immunology.

[523]  W. Paul,et al.  Regulation of IgG1 and IgE Production by Interleukin 4 , 1988, Immunological reviews.

[524]  R. Geha,et al.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes , 1988, The Journal of experimental medicine.

[525]  C. Figdor,et al.  Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. , 1988, Journal of immunology.

[526]  K. Arai,et al.  B cell growth-promoting activity of recombinant human interleukin 4. , 1987, Journal of immunology.

[527]  K. Arai,et al.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes , 1987, The Journal of experimental medicine.

[528]  K. Arai,et al.  Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[529]  R. Coffman,et al.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[530]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[531]  T. Honjo,et al.  Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter , 1986, Nature.